buscopan tablets
boehringer ingelheim limited - hyoscine butylbromide 10 mg - coated tablet
buscopan cramps 10mg tablets
sanofi consumer healthcare - hyoscine butylbromide - oral tablet - 10mg
buscopan rx 10mg coated tablets
sanofi s.r.l viale l. bodio, 37/b 20158, milan, italy - hyoscine butylbromide - coated tablet - hyoscine butylbromide 10 milligram(s) - drugs for functional gastrointestinal disorders
buscopan
pharmacy retailing (nz) ltd t/a healthcare logistics - hyoscine butylbromide 20 mg/ml - solution for injection - 20 mg/ml - active: hyoscine butylbromide 20 mg/ml excipient: sodium chloride water for injection
buscopan suppository
sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide -
buscopan tablets 10mg
sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - hyoscine butylbromide -
buscopan- n-butylscopolammonium bromide injection
boehringer ingelheim animal health usa inc. - butylscopolamine bromide (unii: 0gh9jx37c8) (butylscopolamine - unii:2z3e1of81v) - butylscopolamine bromide 20 mg in 1 ml - buscopan is indicated for the control of abdominal pain (colic) associated with spasmodic colic, flatulent colic, and simple impactions in horses. buscopan should not be used in impaction colics associated with ileus, or in horses with glaucoma.
buscopan tablet
sanofi consumer health inc - hyoscine butylbromide - tablet - 10mg - hyoscine butylbromide 10mg - antimuscarinics antispasmodics
buscopan tablet 10mg
dksh malaysia sdn bhd - hyoscine butylbromide -
gravol tablets
church & dwight canada corp - dimenhydrinate - tablet - 50mg - dimenhydrinate 50mg - antihistamines